MedPath

dark chocolate effect on cardiovascular side effect of diabetes

Not Applicable
Conditions
Diabetes Mellitus type 2.
Non-insulin-dependent diabetes mellitus
Registration Number
IRCT2015022116123N5
Lead Sponsor
Vice Chancellor for Research and Technology, Ahvaz Jundishapur University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

no food supplement consumption; body mass index 18.5-34.9; 30-60 years old; using only blood glucose reducing drugs, Metformin and Glibenclamide; willing to participate. Exclusion criteria: no appropriate corporation; any other disease; Obesity? (body mass index more than 34.9); pregnancy and lactating.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
itric oxide. Timepoint: at the first and at the end of intervention period. Method of measurement: ELISA.;Adiponectin. Timepoint: at the first and at the end of intervention period. Method of measurement: ELISA.;Angiotensin?. Timepoint: at the first and at the end of intervention period. Method of measurement: ELISA.;Interleukine- 6. Timepoint: at the first and at the end of intervention period. Method of measurement: ELISA.;Tumor necrosis Factor-a. Timepoint: at the first and at the end of intervention period. Method of measurement: ELISA.;Blood pressure. Timepoint: at the first and at the end of intervention period. Method of measurement: Mercury sphygmomanometer.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath